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ABSTRACT
In order to investigate the possible relationship between atherosclerosis and chronic Pseudomonas
aeruginosa infection, 66 Wistar rats were given five separate intratracheal inoculations of either
P. aeruginosa or sterile saline at 4-week intervals. The rats were divided into four groups: group 1 was
infected with P. aeruginosa and fed a diet containing cholesterol 1% w ⁄ v; group 2 was infected with
P. aeruginosa and fed a normal diet; group 3 was not infected and was fed a diet containing cholesterol
1% w ⁄ v; and group 4 (the control group) was not infected and was fed a normal diet. One month after
the final inoculation, the rats were killed humanely; computerised image analysis was used to evaluate
sections of the aorta and heart, and the maximal wall thickness of the aorta and coronary artery. The
aortic wall thickness was significantly greater for group 1 (329.53 ± 58.06 lm) compared to groups 2
(190.59 ± 27.81 lm; p < 0.0001), 3 (262.90 ± 61.12 lm; p < 0.0004) and 4 (158.00 ± 30.30 lm; p < 0.0001).
Similarly, the coronary artery wall thickness was significantly greater for group 1 (72.96 ± 10.67 lm)
compared to groups 2 (35.07 ± 8.53 lm; p < 0.0001), 3 (41.45 ± 10.22 lm; p < 0.0001) and 4
(32.30 ± 5.27 lm; p < 0.0001). These findings strengthen the hypothesis that chronic infection plays a
role in the pathogenesis of atherosclerosis.
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INTRODUCTION
Atherosclerotic cardiovascular disease is a major
health problem throughout the world [1].
Although certain risk factors associated with the
development of atherosclerosis have been defined,
the exact mechanisms by which they might con-
tribute to the development of atherosclerosis are
not known fully [2] and many of the risk factors
remain unexplained. Exposure to infectious
agents has been proposed as a possible risk factor
[3], and previous studies have demonstrated the
possible role of several bacteria and viruses in the
development of atherosclerosis [4–6]. Although
infection can affect the atherosclerotic process
directly by inducing a local inflammatory reaction
associated with oxidative and proteolytic proces-
ses and proliferative cell responses, the indirect
effects from distant sites which induce cytokines
and systemic inflammation remain unknown. In
the case of atherosclerosis, risk factors such as
smoking, hypertension, hyperglycaemia, hyperli-
pidaemia and hypercholesterolaemia interact sy-
nergically. The objective of the present study was
to determine whether chronic lung infection with
Pseudomonas aeruginosa would result in the devel-
opment of atherosclerosis in rats fed either a
normal or cholesterol-supplemented diet.
MATERIALS AND METHODS
Bacteria
P. aeruginosa strain ATCC 1942, which has a stable mucoid
phenotype, was used in the study. The bacteria were grown at
37C for 18–24 h on sheep blood agar. The cells were then
scraped from the agar and resuspended in sterile saline to a
density of 5· McFarland standard (OD550 1.25; equivalent to
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c. 1.5 · 109 CFU ⁄mL). The viable count was confirmed by
plating serial dilutions on sheep blood agar and counting
colonies.
Experimental animals and study design
Sixty-six Wistar rats (aged 3 months; pathogen-free) were
used. The rats were divided randomly into four groups, with
14–20 rats ⁄ group. The rats in group 1 (20 rats; four rats died
during the experiment) and group 3 (16 rats; two rats died)
were fed a diet supplemented with cholesterol (Sigma, St
Louis, MO, USA) 1% w ⁄v, while the rats in group 2 (14 rats;
four rats died) and group 4 (16 rats; control group) were fed a
normal diet. Each rat’s trachea was surgically explored under
anaesthesia with titrated intramuscular doses of ketamine
hydrochloride (30–100 mg ⁄ kg) and xylazine hydrochloride
(10–15 mg ⁄kg). Rats in groups 1 and 2 were given 0.1 mL
(1.5 · 109 CFU ⁄mL) of P. aeruginosa suspension intratracheal-
ly, while the rats in groups 3 and 4 were given 0.1 mL sterile
saline via a syringe. This procedure was repeated five times at
4-week intervals. While the rats were anaesthetised, a blood
sample was collected from the tail (0.5 mL) for cholesterol
analysis. Food consumption and weight were recorded each
month. Animal care and processing was performed with strict
adherence to the guidelines of the Institutional Animal Care
and Use Committee.
Six months after the initial inoculation, all rats were killed
humanely for evaluation of the aortic and coronary arteries.
Following opening of the chest cavity under sterile conditions,
the lungs were first removed and prepared for bacteriological
examination, after which the aorta and heart were removed
and sent for histopathological examination.
Bacteriological examination
Lung homogenates were prepared by adding an equal volume
of phosphate-buffered saline to each of the lung tissue
samples. Following homogenisation, 0.1-mL aliquots of appro-
priate dilutions were used to determine the viable count.
Histopathological examination
All histopathological examinations were performed blind by
the pathological team. Representative cross-sections of the
heart, and the thoracic and abdominal aortas, were removed
from each sample and fixed in buffered formalin 10% v ⁄v,
embedded in paraffin wax, and stained with haematoxylin and
eosin. The aorta was divided into three segments (ascending,
descending and abdominal), and 5-lm-thick serial sections
were prepared with a cryotome (Shandon AS 325; Thermo
Electron, Runcorn, UK). Between eight and ten slides prepared
from each segment were inspected visually to select the
segment with greatest luminal narrowing, which was then
examined with a CH 40 microscope (Olympus, Tokyo, Japan).
Finally, the areas of media and the neointima were assessed by
computerised image analysis (Samba 2000; Gateway Comput-
ers, Dublin, Ireland). Three slides with maximal aortic wall
thickness were identified, and three pre-specified measure-
ments, including intima plus media, were made by compu-
terised image analysis for each rat. The microscopic and
computerised image analyses were used to measure the
epicardial coronary artery wall thickness in the heart sections.
Three pre-specified measurements, including intima plus
media, were made, and averages of the three measurements
for each rat’s aorta and coronary artery were used in the
statistical analysis.
Statistics
Serum total cholesterol levels, food consumption and weights
of the rats were expressed as mean ± SD. Food consumption
and the weights of the groups were estimated by analysis of
variance in repeated measures. Maximal aorta and coronary
artery wall thickness, as well as serum total cholesterol levels,
were also evaluated by analysis of variance, with a p value
£ 0.05 considered significant.
RESULTS
Fifty-six rats survived for examination at the end
of the study. There were no statistically significant
differences in food consumption and weight
between the groups. The total serum cholesterol
levels of the rats in groups 1, 2, 3 and 4
were 78.76 ± 7.60 mmol ⁄L, 61.10 ± 8.71 mmol ⁄L,
86.68 ± 16.30 mmol ⁄L and 74.75 ± 12.20 mmol ⁄L,
respectively. The rats in group 2 (infected group
with a normal diet) had significantly less serum
cholesterol (p < 0.0001) than groups 1, 3 and 4.
P. aeruginosa was isolated from the lungs of seven
rats in group 1, and three rats in group 2, but not
from the other groups.
The rats in the control group hadmainly normal
aortic and coronary artery wall structure in cross-
section. However, the rats in the infected group
with a high-cholesterol diet had developed typical
atherosclerosis lesions, not only in the aorta but
also in the epicardial coronary arteries. In unin-
fected rats fed a high-cholesterol diet, there were
marked atherosclerotic lesions in the aorta alone.
Cross-sectional analysis revealed lesions that were
uniformly characteristic of atheromas, with fatty
streaks, various proportions of foamy cells,
smooth muscle cells and extracellular matrix.
The aortic wall thickness was significantly
greater for the infected group fed a high-choles-
terol diet (329.53 ± 58.06 lm) as compared with
the uninfected rats fed a high-cholesterol diet
(262.90 ± 61.12 lm; p 0.004), the infected rats fed
a normal diet (190.59 ± 27.81 lm; p < 0.0001), and
the rats in the control group (158.00 ± 30.30 lm;
p < 0.0001).
The coronary artery wall thickness was signi-
ficantly greater in the infected group fed a high-
cholesterol diet (72.96 ± 10.67 lm) as compared
with the uninfected rats fed a high-cholesterol
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diet (41.45 ± 10.22 lm; p < 0.0001), the infected
rats fed a normal diet (35.07 ± 8.53 lm;
p < 0.0001), and the rats in the control group
(32.30 ± 5.27 lm; p < 0.0001). There was no sig-
nificant difference between uninfected rats fed a
high-cholesterol diet, infected rats fed a normal
diet, and the control group.
DISCUSSION
Chronic infection has been associated previously
with the development of atherosclerosis [2], rais-
ing the possibility that infectious agents may
directly or indirectly trigger the cascade of biolo-
gical and biochemical reactions leading to inflam-
mation, atherosclerosis and vascular thrombotic
events. Infection may cause lethal lytic damage, or
infected cells may survive but show altered
function [7]. Endothelial dysfunction may cause
increased procoagulant activity, cytokine produc-
tion and leucocyte adhesion, and reduced intrin-
sic fibrinolysis. Smooth muscle cell dysfunction
may be associated with increased proliferation,
reduced apoptosis, increased cholesterol esterifi-
cation and increased cytokine production.
Indirect effects on vascular cells may accom-
pany infection or activation of vessel-associated
leukocytes; mononuclear phagocytes may show
increased procoagulant and reduced fibrinolytic
behaviour, altered lipid metabolism, increased
cytokine production and the release of toxic
oxygen species [8]. Furthermore, it can be specu-
lated that infectious agents may have direct and
indirect effects on vascular cells.
After the discovery of the link between infec-
tion and atherosclerosis, several groups have
developed animal models for further study.
Muhlestein et al. [9] showed in a rabbit model
that infection with Chlamydia pneumoniae may
accelerate the development of atherosclerosis, and
that treatment with azithromycin can prevent this
process. With an apoE-deficient mouse model it
has been shown that murine c-herpes viruses and
cytomegalovirus can accelerate atherosclerosis
[10,11]. In mice fed a high-cholesterol diet,
C. pneumoniae strain AR39 may stimulate the
initial atherosclerotic lesions on vessels, although
this is not the case with Chlamydia trachomatis
strain MoPn [12].
Although the study of Hu et al. [12] suggested
that C. pneumoniaemay possess a unique biological
property for its role in stimulating atherogenesis,
the present study investigated a bacterium that
causes chronic infection in other systems, namely
a strain of P. aeruginosa with a mucoid phenotype.
Such organisms have not been isolated previously
from the aortic wall or the coronary artery wall.
However, P. aeruginosa is one of the pathogens that
is isolated most frequently from patients with
chronic pulmonary infections, including cystic
fibrosis. When grown on agar, P. aeruginosa iso-
lates from chronically infected patients generally
have a mucoid appearance. Examination of post-
mortem lung material from patients with cystic
fibrosis shows that formation of the glycocalyx of
Pseudomonas is an in-vivo as well as an in-vitro
phenomenon [13]. The exopolysaccharide pro-
duced by mucoid strains of P. aeruginosa mediates
attachment to epithelial cells and mucins. In
addition, the exopolysaccharide appears to protect
the bacterium from host immune factors such as
phagocytic cells [13]. Cash et al. [14] developed a
model of chronic bronchopulmonary infection in
rats with agarose beads embedded with P. aeru-
ginosa. However, for the present study, it was
decided to administer the organism repeatedly, as
was done with the rat model of C. pneumoniae
infection [9]. Technically, repeated intratracheal
inoculation of bacteria enmeshed in agar beads to
the same location could lead to airway obstruc-
tion, while direct tracheal inoculation of free
P. aeruginosa has been shown to result in an acute
or a transient pulmonary infection [15]. Although
rats challenged with free live P. aeruginosa experi-
enced mild-to-moderate lung pathology in com-
parison with rats challenged with P. aeruginosa
alginate beads, their antibody responses were
comparable, and the immunological responses to
the antigens used were persistent during a 28-day
study period [15]. Yu et al. [16] have used repeated
aerosol administration successfully in attempts to
reproduce the acquisition and pathogenesis of
P. aeruginosa infection seen in cystic fibrosis
patients [16].
Using the repeated administration method, the
infected group of rats fed a normal diet had a
significantly lower serum cholesterol level com-
pared to the other groups. Studies in experimental
animals, as well as in humans, have reported a
decrease in cholesterol levels during infectious
disease [17–19]. Although the underlying mech-
anism for this is unclear, several studies have
suggested that cytokines can modulate lipid meta-
bolism [17,18]. Elevated levels of cytokines such as
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tumour necrosis factor are associated with hypo-
cholesterolaemia [17]. It is unclear whether this
decrease is caused by accelerated clearance of
lipoproteins or diminished synthesis and secretion
of lipoprotein precursors by the liver.
The present study is the first to demonstrate
that infection with P. aeruginosa can stimulate
atherogenesis in rats fed a cholesterol-supplemen-
ted diet. Infection with P. aeruginosa alone did not
induce atherosclerotic lesions. In addition, the
thickness of the coronary artery wall and the aorta
wall was significantly greater in infected rats fed a
cholesterol-supplemented diet, compared with
the other rats. These findings strengthen the case
for the role of chronic infection in the pathogen-
esis of atherosclerosis.
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